Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer
NCT00020631 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2013-06-19
Summary
RATIONALE: Pirfenidone may prevent or lessen fibrosis caused by radiation therapy.
PURPOSE: Pilot trial to study the effectiveness of pirfenidone in preventing or lessening fibrosis in patients who have undergone radiation therapy for cancer.
Conditions
- Radiation Fibrosis
Interventions
- DRUG
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Principal Investigators
-
Kevin Camphausen, MD · NCI - Radiation Oncology Branch; ROB
Study Design
- Purpose
- SUPPORTIVE_CARE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-10-31
- Completion
- 2007-10-31
Countries
- United States
Study Locations
More Related Trials
-
Hypofractionated Radiotherapy for Lung Cancer
NCT00214123 ·Status: COMPLETED ·Phase: PHASE1
-
Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction
NCT00009789 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery to Control Pain
NCT00802659 ·Status: TERMINATED ·Phase: NA
-
Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction
NCT06306638 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
NCT06686771 ·Status: RECRUITING ·Phase: PHASE3
-
Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC)
NCT01416961 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Phase I/II Trial of Stereotactic Body Radiation Therapy
NCT00591838 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases
NCT02159742 ·Status: ACTIVE_NOT_RECRUITING
-
Prospective Patient Registry for Radiation Oncology Techniques and Quality
NCT02368106 ·Status: WITHDRAWN
-
Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation
NCT01345539 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy
NCT00026650 ·Status: RECRUITING
-
Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI
NCT05302817 ·Status: TERMINATED ·Phase: PHASE1
-
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery
NCT00551369 ·Status: COMPLETED ·Phase: PHASE2
-
Measuring the Effect of Radiation Therapy on Patient Activity Levels
NCT02694380 ·Status: TERMINATED
-
A Phase 1 Study of [225Ac]-FPI-1434 Injection
NCT03746431 ·Status: TERMINATED ·Phase: PHASE1
-
Phase 1/2 Study to Determine Optimal Dose for Treating Bone Metastases Using Novel STAT-RT Workflow
NCT02145286 ·Status: UNKNOWN ·Phase: NA
-
Functional Imaging of Treatment Effects: A Companion Protocol to a Study of Extracranial Stereotactic Radioablation in Early Stage Non-Small Cell Lung Cancer
NCT00246116 ·Status: COMPLETED ·Phase: NA
-
Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
NCT00843726 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer
NCT00607828 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer
NCT00087438 ·Status: COMPLETED ·Phase: PHASE2
-
Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)
NCT01158170 ·Status: UNKNOWN ·Phase: PHASE3
-
Ventilation Using Radiographic Examination: Functional Lung Imaging Techniques for the Reduction of Toxicity in Functional Avoidance Radiation Therapy
NCT06159660 ·Status: RECRUITING
-
Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma
NCT06691425 ·Status: RECRUITING ·Phase: NA
-
Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC
NCT00246181 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
NCT03812289 ·Status: TERMINATED ·Phase: NA